How Clinical Trials Are Designed to Protect Participants

The Ethics Behind Clinical Trial Design

Ethics is the foundation of all clinical research. Every clinical trial must demonstrate that it is scientifically valid, socially valuable, and ethically justifiable before it can begin.

At its core, ethical trial design ensures that:

• The potential benefits of the research outweigh the risks
• Participants are fully informed and voluntarily consent to take part
• Participant wellbeing takes priority over research outcomes
• Vulnerable populations are protected

These principles are guided by internationally recognised frameworks such as the Declaration of Helsinki, alongside Australian-specific guidance including the National Statement on Ethical Conduct in Human Research. In Australia, clinical trials must also comply with regulatory oversight from the Therapeutic Goods Administration (TGA). In practice, this means that no clinical trial can proceed without demonstrating:

• A clear scientific rationale
• A defined risk management strategy
• A robust informed consent process
• Ongoing monitoring of participant safety

The Role of Human Research Ethics Committees (HRECs)

In Australia, every clinical trial involving human participants must be reviewed and approved by a Human Research Ethics Committee (HREC).

HRECs are independent bodies made up of medical professionals, researchers, legal experts, and community representatives. Their role is to assess whether a clinical trial is ethically acceptable and whether participant rights and welfare are adequately protected. Key responsibilities of HRECs include:

• Reviewing the study design and scientific validity
• Assessing risks versus potential benefits
• Evaluating participant information and consent forms
• Monitoring ongoing trial conduct and safety reporting

There many other Human Research Ethics Committees operating across Australia, particularly within hospitals, universities, and research institutions such as:

• Alfred Health
• Royal Melbourne Hospital
• Monash Health
• The University of Melbourne

Each of these institutions operates its own HREC, ensuring that research conducted under its oversight meets national ethical standards.

Independent ethics committees  such as Bellberry Limited  which provides independent ethical review services across Australia, are typically accessed by private sites that do not have an affiliated ethics committee, while organisational ethics committees are generally used by their own staff members.

All HRECs in Australia must operate in accordance with the National Statement on Ethical Conduct in Human Research, developed by the National Health and Medical Research Council (NHMRC).

Informed Consent: A Critical Safeguard

A key ethical requirement in any clinical trial is informed consent. Before participating, individuals are provided with detailed information about:

• The purpose of the study
• What participation involves
• Potential risks and benefits
• Alternative treatment options
• Their right to withdraw at any time

This information is typically presented in a Participant Information and Consent Form (PICF), which must be written in clear, understandable language. Consent is not a one-off event. It is an ongoing process, and participants can ask questions or withdraw consent at any stage.

Data Monitoring and Participant Safety

Beyond ethics approval, clinical trials include continuous safety monitoring throughout the study. This is achieved through structured processes such as:

• Regular clinical assessments
• Adverse event reporting
• Independent safety reviews
• Data monitoring committees (DMCs), where applicable

Data Monitoring Committees are independent groups of experts who review accumulating trial data to ensure participant safety. They can recommend modifications to the study, or even stop the trial early if safety concerns arise or if results are conclusive.

Risk Management in Clinical Trials

Every clinical trial is designed with a detailed risk management plan. This includes:

• Identifying potential risks before the trial begins
• Defining how risks will be minimised
• Establishing clear protocols for managing any type of adverse events

Trials often begin with smaller early-phase studies to assess safety before progressing to larger trials involving more participants. This phased approach allows researchers to gather safety data gradually, reducing risk exposure.

What Happens If Something Goes Wrong?

While clinical trials are designed to minimise risk, it is important to acknowledge that unforeseen events can occur. In the event of an issue:

• Participants receive appropriate medical care
• The event is documented and reported to the HREC and relevant authorities
• The trial may be paused or stopped if necessary
• Investigations are conducted to understand the cause

Participants in Australian clinical trials are also protected through compensation frameworks. It is mandatory that clinical trials are covered by insurance  as part of running the study. All trials must adhere to Medicines Australia guidelines regarding compensation for trial-related injury.

Transparency and Accountability in Research

Transparency is another key component of participant protection. Clinical trials are often registered in publicly accessible databases such as the Australian New Zealand Clinical Trials Registry 

Trial registration ensures that:

• Studies are publicly recorded
• Outcomes are reported transparently
• Research duplication is reduced

The Importance of Participant-Centred Research

Modern clinical trials are increasingly designed with participants in mind.

This includes:

• Simplifying consent processes
• Reducing the burden of participation
• Improving communication throughout the trial
• Incorporating patient feedback into study design

This shift reflects a broader move toward more inclusive and accessible healthcare research.

Why These Safeguards Matter

Clinical trials are essential for medical progress, but they must always balance innovation with responsibility.

The systems in place—ethical review, informed consent, safety monitoring, and regulatory oversight—exist to ensure that participants are protected at every step.

Understanding these safeguards can help individuals feel more confident when exploring clinical trial participation.

In Australia 

Clinical trials in Australia are governed by a comprehensive framework designed to protect participants while enabling important medical research.

From the ethical foundations of trial design to the oversight of HRECs, continuous safety monitoring, and clear protocols for managing risks, participant wellbeing remains the central priority.

At White Coats Foundation, increasing awareness and understanding of clinical trials is key to bridging the clinical trial conversation gap. By connecting participants and the public in general with trusted information and resources, we aim to empower informed healthcare decisions.